Consort Medical is a leading global contract development and manufacturing organisation (CDMO), providing advanced delivery technologies, formulation and manufacturing solutions for drugs.
Our customers include some of the world’s largest pharmaceutical companies. Optimising world-class drug delivery device development and manufacture, together with drug Active Pharmaceutical Ingredient (API) and finished dose formulation and manufacture, within the same Group streamlines and accelerates our pharmaceutical customers’ drug route to market.
The Group is at the leading edge of innovation and is committed to investing in patient and customer driven innovation, with the potential to create new treatments, new markets and new opportunities.
We also continue to diversify into adjacent complementary markets and technologies which leverage our core competencies in drug formulation, manufacturing and delivery.
The Group comprises two integrated operating divisions:
Bespak (Devices) — a global market leader in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.
Aesica (Drugs) — a leading pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services.
Optimising world-class drug delivery device development and manufacture, together with drug API and finished dose formulation and manufacture, within the Group streamlines and accelerates our pharmaceutical customers’ drug route to market.